GA · Ophthalmology · 6 drugs · 3 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Sefaxersen | AZN | Factor B inhibition | Antisense oligonucleotide | SC | PHASE3 |
| gefurulimab | AZN | C5 inhibitor | Antibody | SC | PHASE3 |
| Fabhalta | NVS | Complement factor B inhibitor | Small molecule | Oral | APPROVED |
| Izervay | ALPMY | C5 inhibitor (pegylated aptamer) | Pegylated aptamer | Intravitreal | APPROVED |
| Veopoz | REGN | C5 inhibitor | Monoclonal antibody | SC | APPROVED |
| VOYXACT | 4578 | Anti-APRIL Monoclonal Antibody | Monoclonal antibody | SC | APPROVED |